A Pharmaversity® Event
The future of ADCs:
How to overcome challenges in development & manufacturing
A joint event by Simtra BioPharma Solutions and SCHOTT Pharma
Register now How to overcome challenges in development & manufacturing
As Antibody Drug Conjugates (ADCs) continue to pave the way as a future standard in cancer therapy their complex nature introduces challenges at every stage – from early development and fill & finish operations to drug-container interactions.
Join us to uncover effective solutions for safely developing, filling and storing Antibody Drug Conjugates
- Discuss best practices for overcoming ADC formulations and stability challenges with SCHOTT Pharma and Simtra scientists, as well as academics and industry colleagues.
- Discover Simtra BioPharma Solutions laboratories and world-class dedicated oncology filling lines.
- Discover the latest trends in development and manufacturing and learn from renowned scientific experts and industry leaders actively engaged in ADC projects.
- Meet and network with research & development thought leaders in the ADC space.
- From lyophilization to light protection, discover how SCHOTT Pharma’s Specialty Vials help safeguard efficacy and reliability.
- Discuss why container choice is key to safely storing your ADC.
- Tour one of the world‘s largest manufacturing sites for ADCs.
Don’t miss this opportunity to gain valuable insights into overcoming ADC challenges across the entire drug product value chain.
Program at a glance
Keynote Presentation
- Challenges in formulation of highly sensitive biologics
Prof. Dr. Wolfgang Friess, Ludwig-Maximilians-Universität-Munich
Expert Insights from SCHOTT Pharma & Simtra BioPharma Solutions
Primary Packaging for ADCs: Adressing Critical Challenges
- Part 1 – Lyophilization, fogging and light sensitivity
Dr. Bernhard Hladik & Sarawut Künzl, SCHOTT Pharma
- Part 2 - Lyophilization versus liquid formulation
Dr. Bernhard Hladik & Sarawut Künzl, SCHOTT Pharma
- Process Development for a Freeze-Dried Antibody Drug Conjugate | Case Study
Dr. Gregory A. Sacha, Simtra BioPharma Solutions
- Overcoming challenges of critical environmental factors in manufacturing by thorough formulation development
Johanna Weber, Dr. Gregory A. Sacha, Simtra BioPharma Solutions
Exclusive behind-the-scenes tour
Experience an exclusive tour of Simtra's state-of-the-art manufacturing lines and laboratories.
Simtra BioPharma Solutions has a long-standing history in manufacturing Antibody Drug Conjugates and has transferred over 60 programs into its Halle/Westfalen, Germany manufacturing facility including six commercial ADC programs.
The site offers clinical and commercial manufacturing services, with expertise in oncology and ADCs, operating under SafeBridge classification and equipped to handle Category 4 drugs. The facility is currently undergoing a $100 million expansion to offer clients syringe manufacturing capacity as well as liquid and lyophilized vial capacity. An additional $14 million investment to expand its clinical-scale conjugation and purification capabilities for ADCs is set to be operational by late 2025.
For more details, you can see the announcement here.
As part of the ADC symposium you will get an exclusive tour of Simtra's state-of-the-art manufacturing lines and laboratories.
Register now
For more details about the event or the products of Simtra BioPharma Solutions and SCHOTT Pharma, please email: pharma@schott.com
The participation is free of charge and includes the breakfast buffet and lunch and, as well as bus transfers from the hotel to the Simtra site and back to the hotel. Any additional costs and services, including but not limited to travel expenses and hotel accommodation, are to be organized and paid by the participants themselves.
Due to the nature of the event, particularly the Simtra production site tour, the organizers reserve the right to refuse individual participants. After sending your application you will receive a confirmation by E-Mail. The ADC Symposium „The future of ADCs: How to meet challenges in development and manufacturing“ is a joint event by Simtra BioPharma Solutions – a tradename of Baxter Oncology GmbH, Kantstr. 2, 33790 Halle/Westfalen, Germany and SCHOTT Pharma AG & Co. KGaA, Hattenbergstr. 10, 55122 Mainz, Germany.